[Critical review of clinical experimentation with clofibrate in coronary disease].
D000284:Administration, Oral; D000328:Adult; D001161:Arteriosclerosis / Q000150:complications; D001797:Blood Protein Electrophoresis; D002994:Clofibrate / Q000008:administration & dosage / Q000627:therapeutic use*; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D004341:Drug Evaluation; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D014461:Ultracentrifugation
D005230:Fatty Acids, Nonesterified; D008074:Lipoproteins; D002994:Clofibrate
Revisione critica di sperimentazioni cliniche con clofibrato nelle coronaropatie.